Article
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
Antimicrobial agents and chemotherapy - 1 Jan 2003
Aubouy Agnès, Bakary Mohamed, Keundjian Annick, Mbomat Bernard, Makita Jean Ruffin, Migot-Nabias Florence, Cot Michel, Le Bras Jacques, Deloron Philippe
Abstract excerpt
Many African countries currently use a sulfadoxine-pyrimethamine combination (SP) or amodiaquine (AQ) to treat uncomplicated Plasmodium falciparum malaria. Both drugs represent the last inexpensive alternatives to chloroquine. However, resistant P. falciparum populations are largely reported in Africa, and it is compulsory to know the present situation of resistance. The in vivo World Health Organization standard...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
